Viatris
Price & Volume
Stats
See more52W Range | $6.60-$12.49 |
Market Cap | $14.1B |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $14.1B |
Revenue Growth (YoY) | 0.2% |
Gross Profit (12 Mos) | $5.6B |
Diluted EPS | -$3.13 |
News
See moreYahoo Finance • 9 days ago
Viatris Says FDA Approves Octreotide Acetate, Clears MR-146 for Clinical Trials
Yahoo Finance • 9 days ago
FDA Approves Viatris' Generic Sandostatin LAR Depot; To Review Weekly Contraceptive Patch Next July
Yahoo Finance • 10 days ago
Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference
Yahoo Finance • 13 days ago
Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus
About
CEO | Mr. Scott Andrew Smith Ph.D. |
Address | Robert J. Coury Global Center, Canonsburg, PA, United States, 15317 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 30,000 |
